SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-010998
Filing Date
2024-04-04
Accepted
2024-04-04 07:00:15
Documents
14
Period of Report
2024-04-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20240403_8k.htm   iXBRL 8-K 30441
  Complete submission text file 0001437749-24-010998.txt   162818

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240404.xsd EX-101.SCH 3408
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240404_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240404_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240404_pre.xml EX-101.PRE 11583
17 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240403_8k_htm.xml XML 2820
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 24821598
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)